|
|
S&P Pharmaceutical Company Limited - Earning & Dividend Analysis Snapshot
This detailed Report provides an Earnings and Dividends history for S&P Pharmaceutical Company Limited. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
S&P Pharmaceutical Company Limited Formerly known as S&P Pharmaceutical Industry Company Limited. The Group's principal activities are the research, development, manufacture and sale of Chinese, OTC drugs and Tibetan medicines and health products. Other activities include the wholesale and retail of Chinese and biological products. These products are for cardiovascular and respiratory systems in the form of solutions and capsules. Products include Chongcaojing (an essence made from Chinese caterpillar fungus), Chongcao Shensi oral liquid, Yiganjian (hepatitis medicine) and Xinnaoxin (Tibetan medicine for diseases caused by shortage of oxygen), among others. Operations of the Group are carried out in the People's Republic of China.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|